Brief: Koru Medical Systems Receives FDA 510(K) Clearance For Delivery Of Rystiggo
29/01/2026 21:06
Jan 29 (Reuters) - KORU Medical Systems Inc KRMD.O: KORU MEDICAL SYSTEMS RECEIVES FDA 510(K) CLEARANCE FOR DELIVERY OF RYSTIGGO® (ROZANOLIXIZUMAB-NOLI), EXPANDING LABEL FOR FREEDOMEDGE® INFUSION SYSTEM KORU MEDICAL SYSTEMS RECEIVES FDA 510(K) CLEARANCE FOR DELIVERY OF RYSTIGGO® (ROZANOLIXIZUMAB-NOLI), EXPANDING LABEL FOR FREEDOMEDGE® INFUSION SYSTEM Source text: ID:nBw1Zzq72a Further company coverage: KRMD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Koru Medical Systems
See all newsKoru Medical Systems Inc Reports Results For The Quarter Ended June 30: Earnings Summary
KORU Medical Q2 returns to profit on lower manufacturing costs and higher average selling prices
Brief: KORU Medical Systems Q2 Operating Expenses USD 7.2 Million
Koru Medical Systems Inc Expected To Post A Loss Of 2 Cents A Share: Earnings Preview
Brief: Koru Medical Systems - Enters Amendment No. 1 To Supply Agreement With Command Medical Products On June 24, 2026 - SEC Filing